MedPath

Non-contact Endoscopy at Covid-19 Outbreak

Not Applicable
Completed
Conditions
Infectious Disease
Gastrointestinal Disease
Interventions
Device: Non-contact MCE system
Registration Number
NCT04320953
Lead Sponsor
Changhai Hospital
Brief Summary

The COVID-19 outbreak and spread throughout the world now constitutes a global public health emergency. Direct contact between doctors and patients in daily practice bears potential risk of Covid-19 infection, and telemedicine, or non-contact medicine, in this circumstance, offers an ideal solution. Remote controlling capsule endoscopy system for gastric examination was recently developed and applicated in clinical practice.

Detailed Description

The novel non-contact magnetically-controlled capsule endoscopy (MCE) system (Ankon Technologies, China) adds a remote control workstation and a audio-visual exchange system to the original well-establish MCE system, which consists of a robotic magnetic arm, a workstation (now bypassed) and a capsule endoscope, and boasts a 90% sensitivity and 94% specificity for diagnosing gastric focal lesions. This feasibility study aims to evaluate the technical success, clinical success and adverse events of the first clinical application of non-contact MCE system.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Signed the informed consents before joining this study
Exclusion Criteria
  • Dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy
  • Refused abdominal surgery to take out the capsule in case of capsule retention
  • Implanted pacemaker, except the pacemaker is compatible with MRI
  • Other implanted electromedical devices or magnetic metal foreign bodies
  • Pregnancy or suspected pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Non-contact MCE examinationNon-contact MCE systemStudy subject in this arm receives non-contact MCE examination.
Primary Outcome Measures
NameTimeMethod
Technical successDuring the procedure

Maneuvarability of the remote control MCE system

Secondary Outcome Measures
NameTimeMethod
Adverse eventsDuring and within 2 weeks after the procedure

Adverse events during and after the procedure

Clinical successDuring the procedure

Complete observation of the mucosa (\>90% of the mucosa observed) in gastric cardia, fundus, body, angulus, antrum and pylorus

Trial Locations

Locations (1)

Changhai Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath